637 related articles for article (PubMed ID: 12589526)
1. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
[TBL] [Abstract][Full Text] [Related]
2. Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice.
de Oliveira RV; Dall'Igna OP; Tort AB; Schuh JF; Neto PF; Santos Gomes MW; Souza DO; Lara DR
Behav Pharmacol; 2005 Mar; 16(2):79-84. PubMed ID: 15767842
[TBL] [Abstract][Full Text] [Related]
3. Guanosine selectively inhibits locomotor stimulation induced by the NMDA antagonist dizocilpine.
Tort AB; Mantese CE; dos Anjos GM; Dietrich MO; Dall'Igna OP; Souza DO; Lara DR
Behav Brain Res; 2004 Oct; 154(2):417-22. PubMed ID: 15313029
[TBL] [Abstract][Full Text] [Related]
4. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
5. Lack of NMDA receptor involvement in caffeine-induced locomotor stimulation and tolerance in rats.
Powell KR; Holtzman SG
Pharmacol Biochem Behav; 1998 Feb; 59(2):433-8. PubMed ID: 9476992
[TBL] [Abstract][Full Text] [Related]
6. Effects of the cognition impairer MK-801 on learning and memory in mice and rats.
van der Staay FJ; Rutten K; Erb C; Blokland A
Behav Brain Res; 2011 Jun; 220(1):215-29. PubMed ID: 21310186
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic prenatal MK-801 treatment on object recognition, cognitive flexibility, and drug-induced locomotor activity in juvenile and adult rat offspring.
Gallant S; Welch L; Martone P; Shalev U
Behav Brain Res; 2017 Jun; 328():62-69. PubMed ID: 28390877
[TBL] [Abstract][Full Text] [Related]
8. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks.
Parada-Turska J; Turski WA
Neuropharmacology; 1990 Dec; 29(12):1111-6. PubMed ID: 2149871
[TBL] [Abstract][Full Text] [Related]
9. Toluene exposure during the brain growth spurt reduces behavioral responses to noncompetitive N-methyl-D-aspartate receptor antagonists in adult rats.
Chien TH; Chan MH; Tang YC; Chen HH
Psychopharmacology (Berl); 2005 Nov; 182(4):468-74. PubMed ID: 16136300
[TBL] [Abstract][Full Text] [Related]
10. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
11. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.
Abekawa T; Ito K; Nakagawa S; Koyama T
Psychopharmacology (Berl); 2007 Jun; 192(3):303-16. PubMed ID: 17340116
[TBL] [Abstract][Full Text] [Related]
12. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
[TBL] [Abstract][Full Text] [Related]
13. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
Okuyama S; Imagawa Y; Tomisawa K
Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid treatment sensitizes mice to amphetamine-induced locomotion but reduces response to caffeine.
Dall'Igna OP; Hoffmann A; da Silva AL; Souza DO; Lara DR
Neurodegener Dis; 2004; 1(1):38-43. PubMed ID: 16908972
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.
Csernansky JG; Martin M; Shah R; Bertchume A; Colvin J; Dong H
Neuropsychopharmacology; 2005 Dec; 30(12):2135-43. PubMed ID: 15956997
[TBL] [Abstract][Full Text] [Related]
16. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.
Chartoff EH; Heusner CL; Palmiter RD
Neuropsychopharmacology; 2005 Jul; 30(7):1324-33. PubMed ID: 15688082
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of MK-801, a non-competitive NMDA-receptor antagonist, elicits a behavioural deficit of rats in the Active Allothetic Place Avoidance (AAPA) task irrespectively of their intact spatial pretraining.
Stuchlík A; Vales K
Behav Brain Res; 2005 Apr; 159(1):163-71. PubMed ID: 15795010
[TBL] [Abstract][Full Text] [Related]
18. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50 kHz Ultrasonic Vocalizations.
Costa G; Morelli M; Simola N
Int J Neuropsychopharmacol; 2015 May; 18(11):pyv057. PubMed ID: 25991653
[TBL] [Abstract][Full Text] [Related]
20. Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine).
Ranaldi R; Munn E; Neklesa T; Wise RA
Psychopharmacology (Berl); 2000 Aug; 151(2-3):192-201. PubMed ID: 10972465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
